Zaloguj się

Gotowe bibliografie tematyczne / Cancer ratio: pleural fluid lymphocyte count

Spis treści

Artykuły w czasopismach

Gotowa bibliografia na temat „Cancer ratio: pleural fluid lymphocyte count”

Autor: Grafiati

Data publikacji: 2 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cancer ratio: pleural fluid lymphocyte count”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Cancer ratio: pleural fluid lymphocyte count"

1

Verma, Akash, Rucha S. Dagaonkar, Dominic Marshall, John Abisheganaden, and R. W. Light. "Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)." Canadian Respiratory Journal 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/7348239.

Pełny tekst źródła

Streszczenie:

Background. We performed prospective validation of the cancer ratio (serum LDH : pleural ADA ratio), previously reported as predictive of malignant effusion retrospectively, and assessed the effect of combining it with “pleural lymphocyte count” in diagnosing malignant pleural effusion (MPE).Methods. Prospective cohort study of patients hospitalized with lymphocyte predominant exudative pleural effusion in 2015.Results. 118 patients, 84 (71.2%) having MPE and 34 (28.8%) having tuberculous pleural effusion (TPE), were analysed. In multivariate logistic regression analysis, cancer ratio, serum L

Style APA, Harvard, Vancouver, ISO itp.

2

International, Journal of Medical Science and Innovative Research (IJMSIR). "A Cross Sectional Study to Determine The Efficacy of Serum LDH: Pleural Fluid Ada Ratio As A Biomarker of Malignant Pleural Effusion in IRD, SMS Medical College, Jaipur." International Journal of Medical Science and Innovative Research (IJMSIR) 9, no. 4 (2024): 151–58. https://doi.org/10.5281/zenodo.15422923.

Pełny tekst źródła

Streszczenie:

<strong>Abstract</strong> <strong>Introduction</strong>: The malignant pleural effusion is one of the most common causes of exudative pleural effusion. There is no accurate and commonly accepted biochemical marker of MPE, hence using common parameters two ratio serum LDH: pleural fluid ADA (cancer ratio) and cancer ratio: pleural fluid lymphocyte count (cancer ratio plus) derived and their efficacy in identification of MPE is studied. <strong>Methods</strong>: 60 undiagnosed pleural effusion patients were studied in a hospital based cross sectional observational analytical study. The values of

Style APA, Harvard, Vancouver, ISO itp.

3

Popowicz, Natalia, Hui Min Cheah, Cynthia Gregory, et al. "Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance." PLOS ONE 16, no. 4 (2021): e0250628. http://dx.doi.org/10.1371/journal.pone.0250628.

Pełny tekst źródła

Streszczenie:

Predicting survival of patients with malignant pleural effusions (MPEs) is notoriously difficult. A robust prognostic marker can guide clinical decision making. The neutrophil-to-lymphocyte ratio (NLR) in blood has been shown to predict survival in many cancers. Pleural fluid bathes the malignant pleural tissues, thus the NLR of the pleural fluid may reflect more closely the local tumour environment. The objective of this study was to explore the prognostic significance of pleural effusion NLR for MPE. We analysed matched effusion and blood from 117 patients with malignant and 24 with benign p

Style APA, Harvard, Vancouver, ISO itp.

4

Singgih, Venny, Ketut Suryana, Ida Ayu Jasminarti Dwi Kusumawardani, Ni Wayan Candrawati, I. Gede Ketut Sajinadiyasa, and Ida Bagus Ngurah Rai. "Role of pleural fluid interleukin-6, neutrophil-lymphocyte ratio, and monocyte-lymphocyte ratio in distinguishing tuberculous and malignant pleural effusions." International Journal of Advances in Medicine 8, no. 4 (2021): 492. http://dx.doi.org/10.18203/2349-3933.ijam20211046.

Pełny tekst źródła

Streszczenie:

Background: Pleural effusion is caused by various disease, including tuberculosis infection and malignancy. To determine the etiology, immunologic parameters are needed to distinguish tuberculous and malignant pleural effusions, including pleural fluid interleukin-6 (IL-6), neutrophil-lymphocyte ratio (NLR), and monocyte-lymphocyte ratio (MLR).Methods: This was a cross-sectional study, conducted at Sanglah General Hospital in Denpasar from March 2020 to September 2020. Pleural fluid IL-6 and leucocyte differential count were measured from subjects with tuberculous and malignant pleural effusio

Style APA, Harvard, Vancouver, ISO itp.

5

Chalamalasetty, Sai Pooja, Preetam Acharya, Thomas Antony, Anand Ramakrishna, and Himani Kotian. "The Use of “Cancer Ratio” in Differentiating Malignant and Tuberculous Pleural Effusions: Protocol for a Prospective Observational Study." JMIR Research Protocols 13 (December 23, 2024): e56592. https://doi.org/10.2196/56592.

Pełny tekst źródła

Streszczenie:

Background Differentiating between tuberculosis and malignancy as the cause of an exudative lymphocyte predominant pleural effusion is difficult due to similarities in the cellular and biochemical characteristics of the pleural fluid in both conditions. Microbiological tests in tubercular pleural effusions have a poor diagnostic yield, and the long turnaround time for results prevents an early diagnosis. The diagnosis of malignant pleural effusion (MPE) is hampered by a variable yield of pleural fluid cytology and closed pleural biopsy and the fact that thoracoscopy may not be readily availabl

Style APA, Harvard, Vancouver, ISO itp.

6

Ganesan, Natesh, Prasanth Gururaj, and Gangadharan Vadivelu. "Cholesterol pleurisy: a rare complication of tuberculosis." International Journal of Research in Medical Sciences 10, no. 11 (2022): 2689. http://dx.doi.org/10.18203/2320-6012.ijrms20222884.

Pełny tekst źródła

Streszczenie:

Pseudochylothorax (PCT) is a rare form of pleural effusion and is characterized by high cholesterol content and milky pleural fluid. Common causes include tuberculosis, rheumatoid arthritis, paragonimiasis, echinococcosis and neoplasia. A 27-year-old male presented with breathlessness for past 3 years aggravated for past 2 months, swelling in perianal region for 6 months with history of treatment for pulmonary tuberculosis with recurrent left pleural effusion for which intercostal drain (ICD) was inserted. Blood investigations showed elevated total leukocyte count and ESR. Radiological investi

Style APA, Harvard, Vancouver, ISO itp.

7

Gayaf, Mine, and Mustafa Canbaz. "Diagnostic Value of Cancer Ratio Plus Obtained by Dividing Cancer Ratio to Pleural Fluid Lymphocyte in Differentiation Malign Pleural Effusion from Tubercular Pleural Effusion." Turkish Thoracic Journal 20, no. -1 (2019): 6. http://dx.doi.org/10.5152/turkthoracj.2019.06.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Iser, Stephanie, Sarah Hintermair, Alexander Varga, et al. "Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma." Cancers 16, no. 1 (2023): 93. http://dx.doi.org/10.3390/cancers16010093.

Pełny tekst źródła

Streszczenie:

Evoked from asbestos-induced inflammation, pleural mesothelioma represents a fatal diagnosis. Therapy ranges from nihilism to aggressive multimodality regimens. However, it is still unclear who ultimately benefits from which treatment. We aimed to re-challenge inflammatory-related biomarkers’ prognostic value in times of modern immune-oncology and lung-sparing surgery. The biomarkers (leukocytes, hemoglobin, platelets, neutrophils, lymphocytes, monocytes, neutrophil–lymphocyte ratio (NLR), lymphocyte–monocyte ratio (LMR), platelet–lymphocyte ratio (PLR), C-reactive protein (CRP)) and clinical

Style APA, Harvard, Vancouver, ISO itp.

9

Pass, Harvey I., Jessica S. Donington, Shirish M. Gadgeel, et al. "Plasma osteopontin and the prognosis of pleural mesothelioma." Journal of Clinical Oncology 31, no. 15_suppl (2013): 11109. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.11109.

Pełny tekst źródła

Streszczenie:

11109 Background: Cytoreductive surgery for malignant pleural mesothelioma (MPM) should be reserved for patients with favorable tumor biology. Osteopontin (OPN) and the ratio of absolute neutrophil to absolute lymphocyte counts (NLR) have been reported as possible prognostic biomarkers. These were studied with other clinical/ laboratory variables in a mixed surgical/non-surgical MPM population to define independent predictors of survival (OS) and progression (TTP). Methods: Forty-four MPM patients (12 F, 32M; 26 cytoreduction, 18 no cytoreduction; 31 epithelial, 13 non-epithelial; 15 Stage I/I

Style APA, Harvard, Vancouver, ISO itp.

10

Shagdaleev, R. F., E. A. Toneev, A. A. Martynov, M. A. Belova, and A. D. Teryagova. "Prognostic model and calculator for assessing the risk of prolonged pleural effusion after lobectomy." Pirogov Russian Journal of Surgery, no. 6 (June 2, 2025): 26. https://doi.org/10.17116/hirurgia202506126.

Pełny tekst źródła

Streszczenie:

Objective. To develop a nomogram and risk assessment calculator for prolonged pleural effusion after lobectomy for lung cancer. Material and methods. The study was conducted at the Thoracic Oncology Surgery Department of the Ulyanovsk Regional Oncology Dispensary. Patients who underwent lobectomy between January 1, 2022 and January 1, 2024 were included (database registration state No. 2024622456). There were 78 patients including 48 ones without prolonged pleural effusion (PPE) and 30 ones with this complication. After statistical analysis, data bootstrapping and logistic regression calibrati

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!